Clinical trial
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
NCT01554618
Study timeline
Study start (actual)2011-12-02Date precision: day
Registry last updated2021-11-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
PlaceboDRUG
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
BudapestHungary3HoustonTexas, United States1BostonMassachusetts, United States1Los AngelesCalifornia, United States1DallasTexas, United States1NashvilleTennessee, United States1ClevelandOhio, United States1Oklahoma CityOklahoma, United States1New HavenConnecticut, United States1CharlotteNorth Carolina, United States1Chapel HillNorth Carolina, United States1LouisvilleKentucky, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01554618 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.